BioSpace News Archive

Business

Freedom Biosciences Appoints Dr. David Hough as Chief Medical Officer

Freedom Biosciences today announced the appointment of David Hough, MD, as Chief Medical Officer.

November 16, 2022
·
3 min read
Business

InvisiShield Technologies Announces the Appointment of Warner C. Greene, M.D., Ph.D. as President and Chief Scientific Officer

InvisiShield Technologies Ltd., a pre-clinical-stage biotechnology company focused on developing intranasal preventives for major disease-causing respiratory viruses announced the appointment of Warner C. Greene, M.D., Ph.D., as President and Chief Scientific Officer.

November 16, 2022
·
4 min read
Deals

Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company.

November 16, 2022
·
5 min read
New Age for Point-of-Care Diagnostics: PixCell Medical’s HemoScreen Surpasses Leading Lab Hematology Analyzer Sysmex XN in Flagging of Abnormal WBC

A study published in eJHaem Journal of Hematology in August 2022, compared PixCell Medical’s FDA-cleared Point-of-Care 5-part differential CBC analyzer, with Sysmex’s market-established Sysmex XN lab CBC analyzer.

November 16, 2022
·
2 min read
Drug Development

Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

Mineralys Therapeutics, Inc. today announced topline results from the Phase 2 Target-HTN trial in individuals with uncontrolled and resistant hypertension.

November 16, 2022
·
8 min read
Pharm Country

Research Study Confirms Efficacy of Doctor’s Biome Signature Probiotics Blend

A new in vitro research study conducted by the Eurofins Labs confirmed efficacy of Doctor’s Biome proprietary blend of probiotics (10 lactobacilli and 5 bifidobacteria) in inhibition of Clostridium difficile (C. diff); a life-threatening diarrhea-causing bacteria.

November 16, 2022
·
2 min read
Biotech Bay

New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

HeartBeam, Inc. (NASDAQ: BEAT announced today that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended for detection of heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office.

November 16, 2022
·
4 min read
Sirona Biochem Reports Positive Results in Safety Study for Anti-Aging Compound TFC-1326

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce positive results of the clinical safety study for their novel anti-aging compound TFC-1326 1% in formulation, now proven to be a non-irritant and non-sensitizer.

November 16, 2022
·
3 min read
Job Trends

ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease

ImpediMed Limited (ASX: IPD) today announced the details of the third contract extension related to the use of its SOZO® Digital Health Platform in a clinical trial being conducted for AstraZeneca.

November 16, 2022
·
2 min read
Study shows less snacking and reduced meal size, when using Epitomee’s novel weight management aid

Epitomee Medical, a biomedical company, develops unique ingestible devices that deploy targeted therapies along the GI tract, to treat a variety of chronic diseases and metabolic disorders.

November 16, 2022
·
3 min read